Vanda Pharmaceuticals | VNDA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 213.88B 23.43B 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Eli Lilly USD 1.09T 40.33B 2026-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 15.62B 3.09B 2026-11
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 24.93B 1.82B 2026-09
J&J USD 653.61B 42.25B 2026-09
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Ligand Pharmaceuticals USD 6.23B 108M 2026-09
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Novartis USD 328.21B 54.92B 2026-11
Pfizer USD 169.88B 6.47B 2026-11
Sanofi EUR 100.56B 13.53B 2026-11
Takeda JPY 9.26T 1.06T 2026-09
Teva Pharmaceutical Industries USD 152.12B 105.39B 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 4.12B 414M 2026-11